EXP vs IONS · P/E 16, rev $2.26B vs rev $226.6M
Eagle Materials Inc (EXP) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
Eagle Materials Inc (EXP) is a building materials company listed on NYSE.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported EXP revenue for 2025-03-31 was $2.26B. Net income was $463.4M. Revenue was up 0.1% from 2024-03-31 to 2025-03-31. EXP currently screens at market cap $6.59B and trailing P/E 16.2.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
EXP currently screens at market cap $6.59B and trailing P/E 16.2. IONS currently screens at market cap $12.28B.
Not investment advice. Open the EXP and IONS stock pages for the full models.
Not investment advice.